84.84
前日終値:
$85.32
開ける:
$85.76
24時間の取引高:
3.60M
Relative Volume:
0.81
時価総額:
$49.23B
収益:
$5.88B
当期純損益:
$1.34B
株価収益率:
36.12
EPS:
2.3489
ネットキャッシュフロー:
$799.60M
1週間 パフォーマンス:
+1.10%
1か月 パフォーマンス:
+0.12%
6か月 パフォーマンス:
+15.79%
1年 パフォーマンス:
+14.46%
Edwards Lifesciences Corp Stock (EW) Company Profile
名前
Edwards Lifesciences Corp
セクター
電話
(949) 250-2500
住所
ONE EDWARDS WAY, IRVINE, CA
EW を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EW
Edwards Lifesciences Corp
|
84.84 | 49.51B | 5.88B | 1.34B | 799.60M | 2.3489 |
|
ABT
Abbott Laboratories
|
126.71 | 220.59B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
94.48 | 137.79B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
352.58 | 134.49B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
98.30 | 125.28B | 34.76B | 4.79B | 5.21B | 3.7017 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | アップグレード | Jefferies | Hold → Buy |
| 2025-10-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-29 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-04-24 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | アップグレード | Stifel | Hold → Buy |
| 2025-01-16 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-11 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-09-18 | ダウングレード | Jefferies | Buy → Hold |
| 2024-07-31 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-07-25 | ダウングレード | Truist | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-03-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-02-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-11-28 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-03-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | ダウングレード | Bernstein | Outperform → Underperform |
| 2023-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | ダウングレード | Stifel | Buy → Hold |
| 2022-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 開始されました | Mizuho | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-27 | 繰り返されました | Citigroup | Buy |
| 2022-01-27 | 繰り返されました | Evercore ISI | Outperform |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | Stifel | Buy |
| 2022-01-27 | 繰り返されました | UBS | Neutral |
| 2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-07-30 | 繰り返されました | Deutsche Bank | Hold |
| 2021-07-30 | 繰り返されました | Jefferies | Buy |
| 2021-07-30 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-07-30 | 繰り返されました | Oppenheimer | Outperform |
| 2021-07-30 | 繰り返されました | Stifel | Buy |
| 2021-07-30 | 繰り返されました | UBS | Neutral |
| 2021-07-30 | 繰り返されました | Wells Fargo | Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-04-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-11 | 繰り返されました | Canaccord Genuity | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Underperform |
| 2020-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Outperform |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-09-23 | 開始されました | Piper Jaffray | Overweight |
| 2019-07-24 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-18 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Hold |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-10-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | ダウングレード | Guggenheim | Buy → Neutral |
すべてを表示
Edwards Lifesciences Corp (EW) 最新ニュース
Canaccord Genuity Lowers Price Target for Edwards Lifesciences (EW) to $87 | EW Stock News - GuruFocus
Transcatheter Heart Valve Replacement Market Size to Reach USD 19.98 Billion by 2033, Growing at a CAGR of 15.32% – SNS Insider - GlobeNewswire Inc.
Edwards Lifesciences (EW): Reassessing Valuation After Strong Sales Growth and Upgraded Guidance - simplywall.st
Edwards seeks a TAVR two-fer in Medicare coverage petition - BioWorld MedTech
Transcatheter heart valves market to enjoy solid growth - MassDevice
Baird Trims Price Target on Edwards Lifesciences to $87 From $88, Maintains Neutral Rating - marketscreener.com
CMS accepts Edwards request for national TAVR coverage review - MassDevice
Edwards Lifesciences (EW): Analyst Rating Maintained, Price Targ - GuruFocus
BTIG reiterates Buy rating on Edwards Lifesciences stock amid TAVR review - Investing.com
Edwards Lifesciences completes key study on SAPIEN XT THV - MSN
Edwards Lifesciences Resolves $140 Million Harpoon Medical Case - Bloomberg Law News
Edwards Lifesciences Completes Key Study on SAPIEN XT THV - TipRanks
Squarepoint Ops LLC Acquires 50,924 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MSN
Is There Now An Opportunity In Edwards Lifesciences Corporation (NYSE:EW)? - Yahoo Finance
Holocene Advisors LP Buys 1,223,460 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
934,449 Shares in Edwards Lifesciences Corporation $EW Bought by Hudson Bay Capital Management LP - MarketBeat
Hudson Bay Capital Management LP Invests $73.08 Million in Edwards Lifesciences Corporation $EW - MarketBeat
Liontrust Investment Partners LLP Has $112.04 Million Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences (NYSE:EW) VP Donald Bobo Jr Sells 11,386 Shares - MarketBeat
Elevatus Welath Management Makes New Investment in Edwards Lifesciences Corporation $EW - MarketBeat
Bellevue Group AG Sells 82,892 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Banque Transatlantique SA Purchases 24,575 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Insider Sell: Heisz Stone Sells Shares of Edwards Lifesciences C - GuruFocus
VP Bobo Jr Sells 11,386 ($953.7K) Of Edwards Lifesciences Corp [EW] - TradingView — Track All Markets
Edwards Lifesciences (EW) executive reports stock sales and 7,100-share gift - Stock Titan
Edwards Lifesciences (EW) officer exercises options and sells 1,019 shares - Stock Titan
Edwards Lifesciences (EW) director reports sale of 2,615 shares at $83.41 - Stock Titan
Edwards Lifesciences Corp. stock underperforms Friday when compared to competitors - MarketWatch
Shareholder Bobo Donald E Jr Fam Trust Files To Sell 5,900 Of Edwards Lifesciences Corp [EW] - TradingView — Track All Markets
EW (NYSE: EW) Rule 144 filing details planned sale of 5,900 shares - Stock Titan
Edwards Lifesciences (EW) insider plans Rule 144 sale of 2,615 common shares - Stock Titan
Edwards Lifesciences (NYSE: EW) insider files Form 144 to sell 5,487 shares - Stock Titan
Edwards Lifesciences Reports Strong Earnings and Growth - MSN
Nebula Research & Development LLC Sells 16,819 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation $EW Shares Purchased by DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main - MarketBeat
Edwards Lifesciences (NYSE:EW) VP Sells 11,340 Shares - MarketBeat
Edwards Lifesciences (EW) executive reports sale of 2,000 shares on Form 4 - Stock Titan
Edwards Lifesciences (NYSE: EW) investor files Rule 144 to sell 2,000 shares - Stock Titan
Edwards Lifesciences Corporation $EW Shares Sold by Glenview Trust co - MarketBeat
Citigroup Adjusts Edwards Lifesciences Price Target to $101 From $96, Maintains Buy Rating - marketscreener.com
State Street Corp Cuts Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Insider Sold Shares Worth $2,153,373, According to a Recent SEC Filing - marketscreener.com
Daiwa Securities Group Inc. Acquires 24,475 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Bank of Nova Scotia Grows Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Transcript : Edwards Lifesciences CorporationAnalyst/Investor Day - marketscreener.com
Edwards Lifesciences Corp Officer Sells Shares - TradingView — Track All Markets
VP Bobo Jr Sells 11,340 ($950.6K) Of Edwards Lifesciences Corp [EW] - TradingView — Track All Markets
Edwards Lifesciences officer exercises 11,340 options and sells shares | EW SEC FilingForm 4 - Stock Titan
Edwards Lifesciences (EW) CEO reports option exercise and stock sales in Form 4 - Stock Titan
VP Bobo Jr Files To Sell 11,340 Of Edwards Lifesciences Corp [EW] - TradingView — Track All Markets
Edwards Lifesciences Corp (EW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):